Monday, January 14, 2013 1:27:24 AM
Based on the requirements, muscle pharm is probably going for the Equity Standard, which has a 5 consecutive trading day requirement applicable to a closing price of $3.
The $4 bid price is out of the question since the bid dropped below $4, however, Muscle Pharm can still uplist using the closing price of $3 condition since Muscle Pharm meets the condition of having over $6 million average revenues for the past 3 years, which allows muscle pharm to qualify for the $3 closing price alternative.
However, the one thing holding us up is the market value of securities of $15 million.
The application itself takes 4-6 weeks according to the PDF so I can only deduce that the market value is the hold up.
This is all new to me, but this is what my research is telling me.
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM